Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Report: Shortage of Cancer Drugs
A report said that cancer centers are dealing with shortages of carboplatin and cisplatin, drugs that are used to treat cancers.
Health Expert Offers Tips for Coping with Poor Air Quality
With large swaths of the East Coast blanketed with smog, many are worried about their health. Mangala Narasimhan, director of critical care services at Northwell Health, offers some peace of mind with a handful of expert tips for coping with poor air quality. 
Hawaii's Kilauea Begins Erupting After 3-Month Pause
Kilauea, one of the most active volcanoes in the world, began erupting on Wednesday after a three-month pause, displaying spectacular fountains of mesmerizing, glowing lava that's a safe distance from people and structures in a national park on the Big Island.
Experts Warn Covid-19 Wave Looming
Experts are warning about a new Covid-19 wave as 14 of New York City's wastewater treatment plants showed high levels of the disease in the past week.
Load More